Agency Information Collection Activities; Announcement of OMB Approval; Orphan Drugs21 CFR Part 316

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Orphan Drugs--21 CFR Part 316'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).